Evidence map›Paper›PMID 41531563›Full record

ArticleCureus2025

Catecholamine-Induced Reversible Cerebral Vasoconstriction Syndrome: An Overlooked Cause of Thunderclap Headache.

Kiserah Philip, Andrew Ashworth, Ross Paton, Frances McGrane

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kiserah PhilipAcute Internal Medicine, Glasgow Royal Infirmary, Glasgow, GBR.
Andrew AshworthAcute Internal Medicine, Glasgow Royal Infirmary, Glasgow, GBR.
Ross PatonAcute Internal Medicine, Glasgow Royal Infirmary, Glasgow, GBR.
Frances McGraneStroke Medicine, Glasgow Royal Infirmary, Glasgow, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a rare but important cause of thunderclap headache. It is often under-recognized, as the presentation can be variable, and early imaging can be normal. RCVS may be precipitated by catecholaminergic surges, including those from pheochromocytoma. We describe a 35-year-old female patient who presented with recurrent thunderclap headaches, later complicated by acute confusion and transient dysphasia. Initial investigations were unremarkable, but subsequent magnetic resonance imaging (MRI) revealed a transient parieto-occipital lesion and vascular irregularities, prompting consideration of RCVS. Her evolving clinical picture eventually led to the discovery of a large adrenal mass, which was confirmed via biochemical testing as a catecholamine-secreting pheochromocytoma. Surgical resection following appropriate alpha- and beta-blockade resulted in complete symptom resolution and biochemical normalization. This case highlights the diagnostic complexity of RCVS secondary to pheochromocytoma, where the absence of typical imaging features and systemic symptoms delayed diagnosis. Early involvement of the multidisciplinary team can be useful in unraveling complex presentations associated with rare secondary causes of headaches. Pheochromocytoma should be considered a potential trigger for RCVS, particularly in patients with unexplained recurrent headaches and systemic symptoms, as early diagnosis and treatment can lead to symptom resolution and prevent serious complications.

Indexed as

adrenal masscatecholamine excesspheochromocytomareversible cerebral vasoconstriction syndromesecondary headachethunderclap headache

Identifiers

PMID41531563
PMCPMC12794468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.